Announcements Trials
Browse Landscape

Phase

Phase 2 96Phase 3 31Phase 1 18Phase 1/2 15Phase 2/3 4Phase NA 3Phase 4 2

Status

Completed 2

Sponsor Class

OTHER_GOV 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Second Primary 1NSCLC 1Locally Advanced Breast Cancer 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Propofol 6Carboplatin 5Sevoflurane 4Saline Solution 3Paclitaxel 3Nivolumab 3Erlotinib Hydrochloride 3Acetaminophen 3Pemetrexed 2Midazolam 2Lidocaine 2Isoflurane 2Docetaxel 2Desflurane 2Cryotherapy 2Bupivacaine 2Bronchoscopy 2Anesthesia, Inhalation 2trametinib 1sotorasib 1pegfilgrastim 1icotinib 1endostar protein 1durvalumab 1dabrafenib 1capmatinib 1camrelizumab 1beta Carotene 1atezolizumab 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × Docetaxel × Clear all
NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡